Maggie® Autoinjector
Product Description
SHL Medical
-
CH -
2020On CPHI since
-
2Certificates
-
5000+Employees
Company types
Categories
SHL Medical
-
CH
-
2020On CPHI since
-
2Certificates
-
5000+Employees
Company types
More Products from SHL Medical (9)
-
Product Molly® Connected Cap
The Molly® Connected Cap is a compact, retrofittable autoinjector add-on that records and transmits data on patients’ use of the device. Upon cap removal from the Molly device, the Connected Cap becomes active, allowing timestamped data to be relayed either through a smartphone app or smart data transmissi... -
Product Molly® Modular Platform Autoinjector
Molly is a single-dose autoinjector technology developed to help pharma and biotech companies reduce initial investments and expedite development timelines. Built on a proven modular platform, Molly reduces risks during the development process while increasing flexibility in device design and production. A... -
Product Maggie® 5.0 Autoinjector
Maggie® 5.0 is an innovative, large-volume, cartridge-based autoinjector built with SHL’s market-proven Needle Isolation Technology (NIT®). A two-step autoinjector, it was developed with a focus on opening a new pathway for handheld devices to accommodate a wider variety of formulation characteristics, suc... -
Product Needle Isolation Technology (NIT®)
NIT® is a safety solution that eliminates the need for manual needle attachment in cartridge-based injections. It enables cartridges to be built into autoinjectors, supporting treatments beyond the 2.25 mL fill range and lyophilized drugs requiring dual-chamber containers.
Products built with NIT ... -
Product Large-volume & high-viscosity drug delivery solutions
SHL offers a versatile range of autoinjectors and wearable systems that enable the delivery of protein biologics for larger fill volumes and liquid viscosities. These systems are designed to help our customers bring their innovative treatments to the hands of patients.
Products: • Bertha®: 2-step a... -
Product Autoinjector development expertise and capabilities
SHL’s commitment to innovation has driven our leadership in the drug delivery industry. We offer vertically integrated expertise and capabilities to ensure the production of our self-injection systems are delivered with unparalleled speed, quality, and reliability.
Learn more about SHL Medical... -
Product InsulCheck® DOSE Pen Injector Add-On
InsulCheck DOSE by Innovation Zed is a reusable add-on device that automatically transfers injection time and dialed dose units to a mobile application. Built with a customizable sleeve and firmware over-the-air (FOTA) capability, InsulCheck dose can accommodate any pen injector and continuously imp... -
Product VSDI®+NIT® Autoinjector
VSDI+NIT is a cartridge-based autoinjector built with SHL’s Needle Isolation Technology (NIT®). NIT eliminates the need for patients to manually attach the needle before each injection. With cartridge compatibility ranging from 1.5 mL to 3.0 mL, this autoinjector’s dosing variations can be customized to cu... -
Product SDI MIX®+NIT® Autoinjector
SDI MIX+NIT is a dual-chamber disposable autoinjector built with SHL’s NIT (Needle Isolation Technology), which allows cartridge-based injectors to be built into easy-to-use autoinjectors. To accommodate drug formulations that need to be reconstituted prior to patient administration, the device features a ...
SHL Medical resources (19)
-
News SHL Medical achieves EcoVadis® Silver Medal and sets ambitious science-based climate targets
SHL Medical, a world-leading provider of advanced drug delivery solutions, is a proud recipient of the prestigious EcoVadis® Silver Medal for its sustainability performance. The company received further recognition from the Science Based Targets initiative (SBTi) for its near-term emissions targets. -
Brochure Your drug delivery partner with proven track record
From design to mass production, SHL Medical's end-to-end device development infrastructure ensures the lasting value of self-injection systems that we design and develop with our customers. Our comprehensive in-house manufacturing capabilities and expertise include every core competency and value-added services across the product lifecycle. 30 years of pioneering the drug delivery industryOver 50 combination products launchedTop 25 bio/pharmaceutical companies in partnership Over 2,000 granted patents in current portfolio -
News SHL Medical and Lifecore Biomedical enter co-marketing partnership agreement
The partnership between SHL Medical and Lifecore Biomedical will allow the companies to exchange knowledge and experience in their respective fields and provide their customers unparalleled guidance in CDMO services and best-in-class options for drug delivery device development. -
Technical Data SHL Medical Products
Working with leading biotechnology and pharmaceutical companies, we develop advanced drug delivery systems, including disposable and reusable injection devices and systems with fixed or variable dosing, high dose accuracy, and the ability to accommodate high volumes and high viscosities.
-
News SHL Medical launches new webpage for Molly Connected Cap autoinjector
SHL Medical, a leader and front-runner in advanced technologies for autoinjectors and specialty drug delivery systems, announced the launch of a new webpage for its Molly® Connected Cap, a smart, retrofittable add-on for the market-proven Molly modular platform autoinjector. -
Video Make Every Injection Count with Molly® Connected Cap
Ready to embark on a journey where connectivity meets autoinjectors? Dive into the world of SHL Medical’s Molly® Connected Cap and experience the future of healthcare. Driven by its experience with commercializing over three dozen autoinjectors worldwide, including 17 combination product projects from the market-proven Molly modular platform technology, SHL Medical developed the Molly Connected Cap autoinjector – an agile solution that supports remote adherence monitoring for personalized care.
Explore the webpage to learn how Molly Connected Cap can help transform patients’ treatment journey: https://bitly.ws/32ZBu -
News SHL Medical announces strategic alliance program for autoinjector services
SHL Medical is forging alliances with a selection of solutions providers along the drug delivery value chain, including with primary container providers, CMOs/CDMOs, and various service providers and suppliers of primary and secondary packaging, to further strengthen its vertically integrated business model. -
Video Molly® Modular Platform Autoinjector
SHL embarked on a journey of transformation with the Molly® autoinjector. After successfully supporting the development of more than a dozen combination products globally, we decide to take the innovation up a notch.
THIS is the next generation of Molly and Molly 2.25. Built upon a modular platform technology, Molly now offers flexibility beyond a conventional platform model that spans across the development processes.
Get an in-depth understanding of how Molly works to address the varying requirements of the industry and learn more about SHL's offerings at our website.
Visit the Molly website for more information: https://bit.ly/3FkJtzm -
News Webinar: Digitalization of autoinjector manufacturing
In this webinar, the speakers will help you understand the intricacies of digitalization in autoinjector manufacturing, reporting on the key learnings from implementing end-to-end digital processes – from product and process development down to the shop floor and machine monitory systems.
-
Video Maggie®: Rethink Your Self-Injection
The constant evolution of drug formulations across various disease areas opens a wider avenue for subcutaneous drug delivery. SHL Medical's Maggie® is a cartridge-based autoinjector that requires just two steps to operate. Built with the market-proven Needle Isolation Technology (NIT®), the device can accommodate varying formulations with volumes up to 3 mL. Following that, SHL Medical is excited to introduce Maggie 5.0 − the newest member of our NIT device family, developed to potentially accommodate injection volumes previously not considered by traditional autoinjectors. -
News CPHI Podcast Series: Leveraging data science for sustainable autoinjector development
Environmental impact is an area of increasing focus for the pharma and biopharma industries, with companies like Merck, Pfizer and GlaxoSmithKline setting ambitious targets for carbon neutrality and laying plans for waste reduction. -
Video Final Assembly, Labelling and Packaging
SHL’s CMO services were established to create added value for our partners following the successful design and development of their device, resulting in a fully integrated service from device design to commercialization.
-
Sponsored Content SHL partner Innovation Zed announces plans to launch InsulCheck DOSE
SHL Medical and Innovation Zed have announced plans to launch InsulCheck® DOSE in 2022. -
Video The Makings of an Autoinjector
SHL’s commitment to our partners as well as the patients they serve stems from a culture deeply rooted in our corporate vision − that of delivering quality and leadership through innovative solutions that empower people.
-
News SHL Medical publishes its Molly® modular platform technology white paper
This white paper is a retrospective analysis on how the new generation of Molly autoinjectors have incorporated a greater level of flexibility in its design and development model. -
Video The SHL Experience
Through an ensemble of rich multimedia content introducing our expertise and capabilities, visitors will be able to see our machine systems and experts at work on developing the devices that we are so proud of.
-
News SHL Medical launches dynamic webpage for Molly autoinjector technology
SHL Medical announced the launch of its Molly autoinjector webpage. -
Podcast Podcast: Leveraging data science for sustainable autoinjector development
Sustainability is becoming increasingly important in the pharma and biopharma industries, with many companies working to incorporate more eco-friendly materials, minimise waste and improve social impact. One such company is SHL Medical, a producer of advanced delivery devices, who are utilising data science to advance their sustainability goals. In this podcast, we discuss the relationship between data and sustainability and hear from SHL how their data-driven approach has produced ‘win-win scenarios’ for the company, its customers and the planet. -
News Beyond the platform – applying modularity to autoinjector development
SHL’s Molly® and Molly® 2.25 mL autoinjectors are built upon a proven modular platform technology to support shorter development timelines and increased flexibility in device design and production.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance